1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial.
Saved in:
| Title: | 1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial. |
|---|---|
| Authors: | Capdevila, J.1 (AUTHOR), Amthauer, H.2 (AUTHOR), Ansquer, C.3 (AUTHOR), Deshayes, E.4 (AUTHOR), Garcia-Carbonero, R.5 (AUTHOR), Teule, A.6 (AUTHOR), Verberne, H.J.7 (AUTHOR), Cwikla, J.B.8 (AUTHOR), Sri Rajaskanthan, R.9 (AUTHOR), Grana, C.M.10 (AUTHOR), Baum, R.P.11 (AUTHOR), Dierickx, L.O.12 (AUTHOR), Michael, M.13 (AUTHOR), Strosberg, J.R.14 (AUTHOR), de Mestier du Bourg, L.15 (AUTHOR), Kluge, A.16 (AUTHOR), Melnyk, S.17 (AUTHOR), Walter, T.18 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1006-S1006. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420120 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Capdevila%2C+J%2E%22">Capdevila, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amthauer%2C+H%2E%22">Amthauer, H.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ansquer%2C+C%2E%22">Ansquer, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deshayes%2C+E%2E%22">Deshayes, E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garcia-Carbonero%2C+R%2E%22">Garcia-Carbonero, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teule%2C+A%2E%22">Teule, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verberne%2C+H%2EJ%2E%22">Verberne, H.J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cwikla%2C+J%2EB%2E%22">Cwikla, J.B.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sri+Rajaskanthan%2C+R%2E%22">Sri Rajaskanthan, R.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grana%2C+C%2EM%2E%22">Grana, C.M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baum%2C+R%2EP%2E%22">Baum, R.P.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dierickx%2C+L%2EO%2E%22">Dierickx, L.O.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Michael%2C+M%2E%22">Michael, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strosberg%2C+J%2ER%2E%22">Strosberg, J.R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Mestier+du+Bourg%2C+L%2E%22">de Mestier du Bourg, L.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kluge%2C+A%2E%22">Kluge, A.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Melnyk%2C+S%2E%22">Melnyk, S.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Walter%2C+T%2E%22">Walter, T.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1006-S1006. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420120 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2334 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1006 Titles: – TitleFull: 1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Capdevila, J. – PersonEntity: Name: NameFull: Amthauer, H. – PersonEntity: Name: NameFull: Ansquer, C. – PersonEntity: Name: NameFull: Deshayes, E. – PersonEntity: Name: NameFull: Garcia-Carbonero, R. – PersonEntity: Name: NameFull: Teule, A. – PersonEntity: Name: NameFull: Verberne, H.J. – PersonEntity: Name: NameFull: Cwikla, J.B. – PersonEntity: Name: NameFull: Sri Rajaskanthan, R. – PersonEntity: Name: NameFull: Grana, C.M. – PersonEntity: Name: NameFull: Baum, R.P. – PersonEntity: Name: NameFull: Dierickx, L.O. – PersonEntity: Name: NameFull: Michael, M. – PersonEntity: Name: NameFull: Strosberg, J.R. – PersonEntity: Name: NameFull: de Mestier du Bourg, L. – PersonEntity: Name: NameFull: Kluge, A. – PersonEntity: Name: NameFull: Melnyk, S. – PersonEntity: Name: NameFull: Walter, T. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |